glp-1 for binge eating Weight-Loss Drugs Show Promise 17 Million With Disorder, Suggests Study New Insight: GLP‑1 medications—long used

3.5.2 Whole cell as drug carrier The living cell presents a complete system for biological applications, facilitating the encapsulation of therapeutic agents and drug delivery across diverse cell types, while the external membrane ensures strong adhesion (83)

These approaches encompass systemic administration of lactate-enriched solutions to provide metabolic support, as well as interventions aimed at inhibiting lactate production or transport as well as promoting its depletion to disrupt metabolic symbiosis in tumors, highlighting the dual therapeutic potential of lactate (150,151)

Astaxanthin: A marine drug that ameliorates cerebrovascular-damage-associated Alzheimers disease in a zebrafish model via the inhibition of matrix metalloprotease-13

This glucagon-like peptide-1 (GLP-1) receptor agonist encourages insulin secretion from the pancreas, slows gastric emptying, and reduces appetite, resulting in higher energy expenditure and lower food consumption

It is supplied for laboratory research only